Woodline Partners’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,333
| Closed | -$4.2M | – | 614 |
|
|
2023
Q2 | $4.2M | Hold |
3,333
| – | – | 0.05% | 315 |
|
|
2023
Q1 | $4.11M | Hold |
3,333
| – | – | 0.06% | 318 |
|
|
2022
Q4 | $4.07M | Hold |
3,333
| – | – | 0.05% | 346 |
|
|
2022
Q3 | $3.94M | Sell |
3,333
-13,167
| -80% | -$15.6M | 0.06% | 341 |
|
|
2022
Q2 | $19.7M | Hold |
16,500
| – | – | 0.3% | 98 |
|
|
2022
Q1 | $19.6M | Hold |
16,500
| – | – | 0.32% | 94 |
|
|
2021
Q4 | $19.4M | Buy |
+16,500
| New | +$19.4M | 0.28% | 106 |
|